Summary
Abbott Laboratories (ABT) has announced a change in its independent registered public accounting firm. Effective upon the completion of its audit for the fiscal year ending December 31, 2013, and the subsequent filing of its 2013 Form 10-K, the company has dismissed Deloitte & Touche LLP. This decision was approved by the Audit Committee of the Board of Directors on December 14, 2012. Concurrently, Abbott Laboratories has appointed Ernst & Young LLP as its new independent registered public accounting firm, effective for the fiscal year ending December 31, 2014. The filing indicates no disagreements or reportable events with the outgoing auditor, Deloitte & Touche LLP, during the periods in question. Investors should note that this change signifies a transition in the oversight of the company's financial reporting and audits.
Key Highlights
- 1Abbott Laboratories is changing its independent auditor.
- 2Deloitte & Touche LLP has been dismissed as the company's auditor.
- 3The dismissal of Deloitte & Touche LLP is effective after the completion of the 2013 fiscal year audit and 2013 Form 10-K filing.
- 4Ernst & Young LLP has been appointed as the new independent registered public accounting firm.
- 5The appointment of Ernst & Young LLP begins with the fiscal year ending December 31, 2014.
- 6There were no disagreements or reportable events with Deloitte & Touche LLP.
- 7A letter from Deloitte & Touche LLP confirming the disclosures in the 8-K filing is included as an exhibit.